# US Army Medical Research and Material Command

US Army Medical Research and Material Command is an other based in Fort Detrick, United States.

## Overview

- **Organization type:** other
- **Headquarters:** Fort Detrick, United States
- **Region:** North America
- **Address:** United States
- **Assets under management:** Undisclosed
- **Website:** https://mrdc.health.mil

## Regulatory record

- **Reports private funds:** No

## About

The US Army Medical Research and Material Command, part of the US Army Medical Department, coordinates medical R&D across more than a dozen specialized research units including the Walter Reed Army Institute of Research and the US Army Institute of Surgical Research. It was formally established in 1993 as the successor to earlier medical research directorates. Its mission spans basic science through advanced development of medical materiel—vaccines, drugs, diagnostics, devices, and training systems—for military use. USAMRMC's research portfolio covers infectious diseases (malaria, dengue, COVID-19), combat casualty care, blast injury, psychological health, and chemical/biological defense. It manages the Congressionally Directed Medical Research Programs, which fund extramural peer-reviewed research in breast cancer, prostate cancer, and other areas through specific appropriations. Notable products include the FDA-licensed RTS,S malaria vaccine and the freeze-dried plasma used in battlefield transfusions. Geographic footprint is predominantly US-based across installations in Maryland, Texas, Alabama, and Washington state, with international collaborations through overseas labs in Kenya, Thailand, and Germany. The command employs over 5,000 military and civilian personnel across its enterprise; its annual budget exceeds $1 billion, largely from congressional appropriations. It operates as a government research entity, not a private fund or single-family office. Recent operational events include restructuring of its medical materiel development functions: in 2020, the US Army established the Medical Research and Development Command (USAMRDC) as a higher-echelon organization, with USAMRMC becoming a subordinate component focused on research and acquisition under the Army Futures Command's oversight. USAMRMC's structural differentiator is its integration into the military acquisition system: it develops medical products for a single customer—the US warfighter—using federal R&D funding and regulatory pathways specific to military medical countermeasures. Unlike civilian biotech or pharma, it does not seek commercial profit; its mandate is readiness-driven medical capability. Succession follows military command rotation, with a brigadier general typically serving as commander for two to three years.

## Sectors

- Healthcare Services
- Biotechnology
- Defense & Government Services
- Medical Devices
- Infrastructure

## Questions

### How is USAMRMC organized?

USAMRMC is part of the US Army Medical Department and under the command of a brigadier general. It includes multiple subordinate commands: the Walter Reed Army Institute of Research (infectious disease), the US Army Institute of Surgical Research (burn and trauma), and the US Army Medical Materiel Development Activity (acquisition). The command was restructured in 2020 under the new US Army Medical Research and Development Command (per Department of Defense organizational documents).

## Related profiles

- [Vetamer Capital](https://altss.com/profile/vetamer-capital)
- [GE32 Capital](https://altss.com/profile/ge32-capital)

---

Last updated: 2026-07-10T13:05:52.000Z

Canonical page: https://altss.com/profile/us-army-medical-research-and-material-command

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology